Federal Register / Vol. 87, No. 88 / Friday, May 6, 2022 / Notices 27155 

standards published by organizations 

such as the American National 

Standards Institute (ANSI), American 

Society for Testing and Materials 

(ASTM) International, and International 

Organization for Standardization (ISO). 

Thus, the information collected from 

human subjects in a laboratory setting is 

generally consistent across NPPTL 

studies with only the boundary 

conditions changing (e.g., 

environmental conditions such as heat 

or humidity, human subject activity 

such as simulated surgery or climbing a 

ladder, and distance between two 

subjects communicating by spoken 

word). Additionally, novel PPT designs 

may be examined or compared to 

commercially available products under 

similar boundary conditions to examine 

adherence to regulations and/or 

standards. NPPTL requests a new 

Generic information collection package 

for laboratory-collected information for 

testing respirators and personal 

protective clothing. 

NIOSH estimates that up to 1,500 

individuals could be burdened per year. 

Recruitment for all laboratory studies 

includes individuals from the general 

population rather than specific 

industries or working status. These 

individuals are all adults between the 

ages of 18 and 65 years. CDC requests 

OMB approval for an estimated 11,903 

annual burden hours. There is no cost 

to respondents other than their time to 

participate. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of 

respondents Form name Number of respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

(in hours) 

Members of the 

general public.

Informed Consent ......................................................... 470 1 30/60 235 

Health Screening Questionnaire ................................... 470 6 1 2820 

Demographics Questionnaire ....................................... 470 1 30/60 235 

Job-related Data: Occupational Tasks, postures used, 

duration of exposure.

470 1 15/60 118 

Physiological Measurements: Chest-worn heart rate 

monitor strap, COSMED Kb5, SQ2020–1F8 temperature logger, TOSCA 500 pulse oximeter, koken 

breathing waveform recording mask.

200 6 1.5 1800 

Biological Measurements: Cortisol (stress) levels, 

pregnancy tests, hydration status, lipids, inflammatory markers, heat shock proteins.

100 6 15/60 150 

Anthropometric Measurements: Calipers/digital measuring of facial and body dimensions.500 1 15/60 125 

Respirator Fit Measurements: Filter cassettes with air 

pumps, fit-testing equipment, QLFT/sodium saccharin solution.

225 100 15/60 5,625 

Self-Perception Data: Level of exertion, perceived 

comfort level, heat sensation, fatigue.

500 6 15/60 750 

Biomechanics Measurements: Force plate, stopwatch, 

accelerometers.

30 3 30/60 45 

Total .............. ....................................................................................... ........................ ........................ ........................ 11,903 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2022–09784 Filed 5–5–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–22–22ET; Docket No. CDC–2022– 

0060] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other federal 

agencies the opportunity to comment on 

a proposed information collection, as 

required by the Paperwork Reduction 

Act of 1995. This notice invites 

comment on a proposed information 

collection project titled Traveler-based 

SARS–CoV–2 Genomic Surveillance. 

The information collection will monitor 

for the importation of SARS–CoV–2 

variants among arriving international air 

travelers at select U.S. airports. 

DATES: CDC must receive written 

comments on or before July 5, 2022. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2022– 

0060 by either of the following methods: 

• Federal eRulemaking Portal: 

www.regulations.gov. Follow the 

instructions for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS H21–8, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

www.regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(www.regulations.gov) or by U.S. mail to 

the address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffrey M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 


JSPEARS on DSK121TN23PROD with NOTICES1
27156 Federal Register / Vol. 87, No. 88 / Friday, May 6, 2022 / Notices 

Prevention, 1600 Clifton Road NE, MS 

H21–8, Atlanta, Georgia 30329; 

Telephone: 404–639–7570; Email: omb@

cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses; and 

5. Assess information collection costs. 

Proposed Project 

Traveler-based SARS–CoV–2 

Genomic Surveillance—New—National 

Center for Emerging and Zoonotic 

Infectious Diseases (NCEZID), Centers 

for Disease Control and Prevention 

(CDC). 

Background and Brief Description 

The traveler-based SARS–CoV–2 

genomic surveillance project was 

developed as a surveillance platform for 

early detection of imported and 

emerging SARS–CoV–2 variants among 

international air travelers arriving into 

the United States. Despite layered 

mitigation measures, international travel 

facilitates spread of SARS–CoV–2, 

including novel variants of concern 

(VOCs). Although SARS–CoV–2 

genomic sequencing has increased 

significantly during the pandemic, there 

is still a gap in early detection of 

emerging variants among arriving 

travelers. 

To address this gap, in September 

2021, the Travelers’ Health Branch, in 

collaboration with private partners, 

implemented a voluntary SARS–CoV–2 

genomic surveillance program with the 

goal of early detection of novel VOCs. 

Surveillance for new and emerging 

variant strains among travelers can 

provide researchers and public health 

officials critical time to collect 

information about the transmissibility, 

virulence, and effectiveness of existing 

vaccines, diagnostics, and therapeutics. 

The project is conducted with external 

partners and groups within DGMQ and 

across CDC, including the Office of 

Advanced Molecular Detection. The 

program began at New York’s John F. 

Kennedy International Airport in 

September 2021 and later expanded to 

include Newark Liberty International, 

San Francisco International, and 

Hartsfield-Jackson Atlanta International 

airports. Information collection for this 

project is currently approved under a 

Public Health Emergency PRA Waiver. 

Project data is collected as follows: A 

volunteer sample of travelers, 18 years 

and older, from selected flights from 

South Asia, South America, Europe, and 

southern Africa, complete an informed 

consent form and fill-out a 

questionnaire on enrollment at the 

airport. The questionnaire includes 

demographic, travel, and clinical 

information. The voluntary surveillance 

project also includes laboratory data 

collection as follows: Airport collection 

of nasal samples from arriving travelers 

and follow-up collection of individual 

at-home saliva samples 3–5 days later. 

Travelers participating in individual, at 

home sample collection also complete 

an electronic health information 

questionnaire prior to submission of 

their samples and have the opportunity 

to fill out an evaluation survey. 

CDC requests OMB approval for an 

estimated 169,433 annual burden hours. 

There is no cost to respondents other 

than their time to participate. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total 

burden 

(in hours) 

Participant with sample collected inairport.Participant information intake form 

(for pooled testing).

88,400 1 1 88,400 

Participant with sample collected at 

home.

Participant intake form (for individual 

at-home testing).

44,200 1 1.5 66,300 

Participant with sample collection athome.Evaluation Survey Form ................... 44,200 1 20/60 14,733 

Total ........................................... ........................................................... ........................ ........................ ........................ 169,433 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2022–09786 Filed 5–5–22; 8:45 am] 

BILLING CODE 4163–18–P 


JSPEARS on DSK121TN23PROD with NOTICES1